AFib is the most common sustained cardiac arrhythmia in adults globally and is associated with significant morbidity, mortality, and economic burden. The prevalence of AFib in adults is currently estimated at between 2% and 4%, with projections indicating a 2.3-fold increase due to longer life expectancy and improved detection of undiagnosed cases.2
Age is a major risk factor for AFib, but the increasing prevalence of other comorbidities such as hypertension, diabetes, heart failure (HF), coronary artery disease, chronic kidney disease,...
